Nanotechnology and Oncology :: Workshop Summary /
"One way scientists are working to overcome challenges in cancer treatment and improve cancer care is through nanotechnology. Nanotechnology, engineered materials that make use of the unique physical properties, presents a new array of medical prospects that will revolutionize cancer prevention...
Gespeichert in:
| Körperschaften: | , |
|---|---|
| Weitere Verfasser: | , |
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Washington, D.C. :
National Academies Press,
©2011.
|
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Zusammenfassung: | "One way scientists are working to overcome challenges in cancer treatment and improve cancer care is through nanotechnology. Nanotechnology, engineered materials that make use of the unique physical properties, presents a new array of medical prospects that will revolutionize cancer prevention, diagnosis, and treatment practices. Giving new hope to patients, practitioners, and researchers alike, nanotechnology has the potential to translate recent discoveries in cancer biology into clinical advances in oncology. While public investments in nanotechnology for cancer continue to increase, medical products based on nanotechnology are already on the market. The National Cancer Policy forum held a workshop July 12-13, 2010, to explore challenges in the use of nanotechnology in oncology. Nanotechnology and Oncology evaluates the ongoing discussion on the role of nanotechnology in cancer as it relates to risk management, treatment, and regulatory policy. Assessments on nanomedicine and the physical properties of nanomaterials were presented during the workshop, along with an appraisal of the current status of research and development efforts."--Publisher's Website |
| Beschreibung: | 1 online resource (xii, 106 pages :) |
| Bibliographie: | Includes bibliographical references (pages 69-71). |
| ISBN: | 9780309163224 0309163226 1283151731 9781283151733 9786613151735 6613151734 0309305594 9780309305594 |
Internformat
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBA-ocn746945424 | ||
| 003 | OCoLC | ||
| 005 | 20240705115654.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 110816s2011 dcua ob 100 0 eng d | ||
| 010 | |a 2012472834 | ||
| 040 | |a N$T |b eng |e pn |c N$T |d IDEBK |d CDX |d NTE |d ORU |d OCLCQ |d E7B |d OCLCQ |d ZMC |d YDXCP |d OCLCQ |d DEBSZ |d COO |d OCLCQ |d OCLCO |d OCLCQ |d NLGGC |d OCLCO |d OCLCQ |d OCLCO |d SE4M6 |d OCLCF |d OCLCO |d EBLCP |d OCLCO |d OCLCQ |d OCLCO |d NKT |d OCLCO |d OCL |d OCLCO |d AZK |d OCLCO |d JBG |d OCLCO |d LOA |d OCLCO |d OCLCA |d TOA |d OCLCO |d AGLDB |d DGU |d MOR |d PIFAG |d OCLCQ |d ZCU |d OCLCQ |d MERUC |d OCLCQ |d MERER |d NJR |d OCLCQ |d U3W |d BUF |d OCLCO |d OCLCQ |d OCLCO |d CUY |d OCLCQ |d STF |d WRM |d VNS |d OCLCO |d OCLCQ |d VTS |d OCLCO |d COCUF |d EZ9 |d OCLCQ |d ICG |d OCLCO |d INT |d OCLCO |d VT2 |d OCLCQ |d OCLCO |d WYU |d LVT |d OCLCQ |d OCLCO |d DKC |d OCLCQ |d M8D |d UX1 |d UHL |d UKAHL |d OCLCQ |d UKCRE |d VLY |d OCLCQ |d OCLCO |d DST |d OCLCQ |d OCLCO |d OCLCQ |d INARC |d OCLCO |d OCLCL |d OCLCQ |d OCLCL | ||
| 016 | 7 | |a 101567107 |2 DNLM | |
| 016 | 7 | |a 015878001 |2 Uk | |
| 019 | |a 741455473 |a 791613741 |a 816847329 |a 923284141 |a 961513860 |a 962580552 |a 966220909 |a 988459098 |a 992034183 |a 1037925520 |a 1038668230 |a 1047527569 |a 1055333944 |a 1064743238 |a 1081258813 |a 1113012512 |a 1153482286 |a 1156365521 |a 1162521273 |a 1228528445 |a 1241920988 |a 1249230411 |a 1290065880 |a 1300448710 |a 1392370514 | ||
| 020 | |a 9780309163224 |q (electronic bk.) | ||
| 020 | |a 0309163226 |q (electronic bk.) | ||
| 020 | |a 1283151731 | ||
| 020 | |a 9781283151733 | ||
| 020 | |a 9786613151735 | ||
| 020 | |a 6613151734 | ||
| 020 | |z 0309163218 | ||
| 020 | |z 9780309163217 | ||
| 020 | |a 0309305594 | ||
| 020 | |a 9780309305594 | ||
| 035 | |a (OCoLC)746945424 |z (OCoLC)741455473 |z (OCoLC)791613741 |z (OCoLC)816847329 |z (OCoLC)923284141 |z (OCoLC)961513860 |z (OCoLC)962580552 |z (OCoLC)966220909 |z (OCoLC)988459098 |z (OCoLC)992034183 |z (OCoLC)1037925520 |z (OCoLC)1038668230 |z (OCoLC)1047527569 |z (OCoLC)1055333944 |z (OCoLC)1064743238 |z (OCoLC)1081258813 |z (OCoLC)1113012512 |z (OCoLC)1153482286 |z (OCoLC)1156365521 |z (OCoLC)1162521273 |z (OCoLC)1228528445 |z (OCoLC)1241920988 |z (OCoLC)1249230411 |z (OCoLC)1290065880 |z (OCoLC)1300448710 |z (OCoLC)1392370514 | ||
| 037 | |a 315173 |b MIL | ||
| 043 | |a n-us--- | ||
| 050 | 4 | |a R857.N34 |b N375 2011eb | |
| 060 | 4 | |a 2011 I-118 | |
| 060 | 4 | |a QZ 200 | |
| 072 | 7 | |a MED |x 003040 |2 bisacsh | |
| 072 | 7 | |a MED |x 009000 |2 bisacsh | |
| 072 | 7 | |a MED |x 029000 |2 bisacsh | |
| 072 | 7 | |a MED |x 048000 |2 bisacsh | |
| 072 | 7 | |a TEC |x 059000 |2 bisacsh | |
| 082 | 7 | |a 610.28 |2 23 | |
| 049 | |a MAIN | ||
| 245 | 0 | 0 | |a Nanotechnology and Oncology : |b Workshop Summary / |c Margie Patlak and Christine Micheel, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies. |
| 260 | |a Washington, D.C. : |b National Academies Press, |c ©2011. | ||
| 300 | |a 1 online resource (xii, 106 pages :) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 504 | |a Includes bibliographical references (pages 69-71). | ||
| 505 | 0 | 0 | |t Introduction -- |t Uses of Nanotechnology in Oncology and Cancer Research -- |t Research and Development of New Cancer Nanomedicines -- Challenges and Solutions -- |t Risks Associated with Nanotechnology -- |t Standards and Regulation -- |t Nanotechnology and the Public -- |t Additional Challenges -- |t Concluding Remarks. |
| 520 | |a "One way scientists are working to overcome challenges in cancer treatment and improve cancer care is through nanotechnology. Nanotechnology, engineered materials that make use of the unique physical properties, presents a new array of medical prospects that will revolutionize cancer prevention, diagnosis, and treatment practices. Giving new hope to patients, practitioners, and researchers alike, nanotechnology has the potential to translate recent discoveries in cancer biology into clinical advances in oncology. While public investments in nanotechnology for cancer continue to increase, medical products based on nanotechnology are already on the market. The National Cancer Policy forum held a workshop July 12-13, 2010, to explore challenges in the use of nanotechnology in oncology. Nanotechnology and Oncology evaluates the ongoing discussion on the role of nanotechnology in cancer as it relates to risk management, treatment, and regulatory policy. Assessments on nanomedicine and the physical properties of nanomaterials were presented during the workshop, along with an appraisal of the current status of research and development efforts."--Publisher's Website | ||
| 588 | 0 | |a Print version record. | |
| 546 | |a English. | ||
| 650 | 0 | |a Nanomedicine |v Congresses. | |
| 650 | 0 | |a Oncology |x Research |z United States |v Congresses. | |
| 650 | 0 | |a Nanotechnology |v Congresses. | |
| 650 | 0 | |a Cancer |x Treatment |v Congresses. | |
| 650 | 1 | 2 | |a Neoplasms |x therapy |0 https://id.nlm.nih.gov/mesh/D009369Q000628 |
| 650 | 6 | |a Cancérologie |x Recherche |z États-Unis |v Congrès. | |
| 650 | 6 | |a Cancer |x Traitement |v Congrès. | |
| 650 | 6 | |a Nanomédecine |v Congrès. | |
| 650 | 6 | |a Nanotechnologie |v Congrès. | |
| 650 | 7 | |a MEDICAL |x Allied Health Services |x Medical Technology. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Biotechnology. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Family & General Practice. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Lasers in Medicine. |2 bisacsh | |
| 650 | 7 | |a TECHNOLOGY & ENGINEERING |x Biomedical. |2 bisacsh | |
| 650 | 7 | |a Cancer |x Treatment |2 fast | |
| 650 | 7 | |a Nanomedicine |2 fast | |
| 650 | 7 | |a Nanotechnology |2 fast | |
| 650 | 7 | |a Oncology |x Research |2 fast | |
| 651 | 7 | |a United States |2 fast |1 https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq | |
| 655 | 2 | |a Congress |0 https://id.nlm.nih.gov/mesh/D016423 | |
| 655 | 7 | |a proceedings (reports) |2 aat | |
| 655 | 7 | |a Conference papers and proceedings |2 fast | |
| 655 | 7 | |a Conference papers and proceedings. |2 lcgft |0 http://id.loc.gov/authorities/genreForms/gf2014026068 | |
| 655 | 7 | |a Actes de congrès. |2 rvmgf | |
| 700 | 1 | |a Patlak, Margie. | |
| 700 | 1 | |a Micheel, Christine. | |
| 710 | 2 | |a Institute of Medicine (U.S.). |b Planning Committee on Policy Issues in Nanotechnology and Oncology. |0 http://id.loc.gov/authorities/names/n2011183420 | |
| 710 | 2 | |a National Cancer Policy Forum (U.S.) |0 http://id.loc.gov/authorities/names/n2006183479 | |
| 758 | |i has work: |a Nanotechnology and Oncology (Text) |1 https://id.oclc.org/worldcat/entity/E39PCFwhKGhgMmbYmD6tPTHcT3 |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |t Nanotechnology and oncology. |d Washington, D.C. : National Academies Press, ©2011 |z 0309163218 |w (OCoLC)705518868 |
| 856 | 1 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=375279 |3 Volltext | |
| 856 | 1 | |l CBO01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=375279 |3 Volltext | |
| 938 | |a Askews and Holts Library Services |b ASKH |n AH36617945 | ||
| 938 | |a Askews and Holts Library Services |b ASKH |n AH36559524 | ||
| 938 | |a Coutts Information Services |b COUT |n 18113815 | ||
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL3378852 | ||
| 938 | |a ebrary |b EBRY |n ebr10495452 | ||
| 938 | |a EBSCOhost |b EBSC |n 375279 | ||
| 938 | |a ProQuest MyiLibrary Digital eBook Collection |b IDEB |n 315173 | ||
| 938 | |a YBP Library Services |b YANK |n 7082324 | ||
| 938 | |a Internet Archive |b INAR |n nanotechnologyon0000unse | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBA | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-4-EBA-ocn746945424 |
|---|---|
| _version_ | 1813903409644830721 |
| adam_text | |
| any_adam_object | |
| author2 | Patlak, Margie Micheel, Christine |
| author2_role | |
| author2_variant | m p mp c m cm |
| author_corporate | Institute of Medicine (U.S.). Planning Committee on Policy Issues in Nanotechnology and Oncology National Cancer Policy Forum (U.S.) |
| author_corporate_role | |
| author_facet | Patlak, Margie Micheel, Christine Institute of Medicine (U.S.). Planning Committee on Policy Issues in Nanotechnology and Oncology National Cancer Policy Forum (U.S.) |
| author_sort | Patlak, Margie |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | R - Medicine |
| callnumber-label | R857 |
| callnumber-raw | R857.N34 N375 2011eb |
| callnumber-search | R857.N34 N375 2011eb |
| callnumber-sort | R 3857 N34 N375 42011EB |
| callnumber-subject | R - General Medicine |
| collection | ZDB-4-EBA |
| contents | Introduction -- Uses of Nanotechnology in Oncology and Cancer Research -- Research and Development of New Cancer Nanomedicines -- Challenges and Solutions -- Risks Associated with Nanotechnology -- Standards and Regulation -- Nanotechnology and the Public -- Additional Challenges -- Concluding Remarks. |
| ctrlnum | (OCoLC)746945424 |
| dewey-full | 610.28 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 610 - Medicine and health |
| dewey-raw | 610.28 |
| dewey-search | 610.28 |
| dewey-sort | 3610.28 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>07235cam a2201057 a 4500</leader><controlfield tag="001">ZDB-4-EBA-ocn746945424</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20240705115654.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr cnu---unuuu</controlfield><controlfield tag="008">110816s2011 dcua ob 100 0 eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a"> 2012472834</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">N$T</subfield><subfield code="b">eng</subfield><subfield code="e">pn</subfield><subfield code="c">N$T</subfield><subfield code="d">IDEBK</subfield><subfield code="d">CDX</subfield><subfield code="d">NTE</subfield><subfield code="d">ORU</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">E7B</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">ZMC</subfield><subfield code="d">YDXCP</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">DEBSZ</subfield><subfield code="d">COO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">NLGGC</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">SE4M6</subfield><subfield code="d">OCLCF</subfield><subfield code="d">OCLCO</subfield><subfield code="d">EBLCP</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">NKT</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCL</subfield><subfield code="d">OCLCO</subfield><subfield code="d">AZK</subfield><subfield code="d">OCLCO</subfield><subfield code="d">JBG</subfield><subfield code="d">OCLCO</subfield><subfield code="d">LOA</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCA</subfield><subfield code="d">TOA</subfield><subfield code="d">OCLCO</subfield><subfield code="d">AGLDB</subfield><subfield code="d">DGU</subfield><subfield code="d">MOR</subfield><subfield code="d">PIFAG</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">ZCU</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">MERUC</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">MERER</subfield><subfield code="d">NJR</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">U3W</subfield><subfield code="d">BUF</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">CUY</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">STF</subfield><subfield code="d">WRM</subfield><subfield code="d">VNS</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">VTS</subfield><subfield code="d">OCLCO</subfield><subfield code="d">COCUF</subfield><subfield code="d">EZ9</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">ICG</subfield><subfield code="d">OCLCO</subfield><subfield code="d">INT</subfield><subfield code="d">OCLCO</subfield><subfield code="d">VT2</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">WYU</subfield><subfield code="d">LVT</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">DKC</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">M8D</subfield><subfield code="d">UX1</subfield><subfield code="d">UHL</subfield><subfield code="d">UKAHL</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">UKCRE</subfield><subfield code="d">VLY</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">DST</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">INARC</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCL</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCL</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">101567107</subfield><subfield code="2">DNLM</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">015878001</subfield><subfield code="2">Uk</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">741455473</subfield><subfield code="a">791613741</subfield><subfield code="a">816847329</subfield><subfield code="a">923284141</subfield><subfield code="a">961513860</subfield><subfield code="a">962580552</subfield><subfield code="a">966220909</subfield><subfield code="a">988459098</subfield><subfield code="a">992034183</subfield><subfield code="a">1037925520</subfield><subfield code="a">1038668230</subfield><subfield code="a">1047527569</subfield><subfield code="a">1055333944</subfield><subfield code="a">1064743238</subfield><subfield code="a">1081258813</subfield><subfield code="a">1113012512</subfield><subfield code="a">1153482286</subfield><subfield code="a">1156365521</subfield><subfield code="a">1162521273</subfield><subfield code="a">1228528445</subfield><subfield code="a">1241920988</subfield><subfield code="a">1249230411</subfield><subfield code="a">1290065880</subfield><subfield code="a">1300448710</subfield><subfield code="a">1392370514</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309163224</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309163226</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1283151731</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781283151733</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9786613151735</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">6613151734</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">0309163218</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9780309163217</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309305594</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309305594</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)746945424</subfield><subfield code="z">(OCoLC)741455473</subfield><subfield code="z">(OCoLC)791613741</subfield><subfield code="z">(OCoLC)816847329</subfield><subfield code="z">(OCoLC)923284141</subfield><subfield code="z">(OCoLC)961513860</subfield><subfield code="z">(OCoLC)962580552</subfield><subfield code="z">(OCoLC)966220909</subfield><subfield code="z">(OCoLC)988459098</subfield><subfield code="z">(OCoLC)992034183</subfield><subfield code="z">(OCoLC)1037925520</subfield><subfield code="z">(OCoLC)1038668230</subfield><subfield code="z">(OCoLC)1047527569</subfield><subfield code="z">(OCoLC)1055333944</subfield><subfield code="z">(OCoLC)1064743238</subfield><subfield code="z">(OCoLC)1081258813</subfield><subfield code="z">(OCoLC)1113012512</subfield><subfield code="z">(OCoLC)1153482286</subfield><subfield code="z">(OCoLC)1156365521</subfield><subfield code="z">(OCoLC)1162521273</subfield><subfield code="z">(OCoLC)1228528445</subfield><subfield code="z">(OCoLC)1241920988</subfield><subfield code="z">(OCoLC)1249230411</subfield><subfield code="z">(OCoLC)1290065880</subfield><subfield code="z">(OCoLC)1300448710</subfield><subfield code="z">(OCoLC)1392370514</subfield></datafield><datafield tag="037" ind1=" " ind2=" "><subfield code="a">315173</subfield><subfield code="b">MIL</subfield></datafield><datafield tag="043" ind1=" " ind2=" "><subfield code="a">n-us---</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">R857.N34</subfield><subfield code="b">N375 2011eb</subfield></datafield><datafield tag="060" ind1=" " ind2="4"><subfield code="a">2011 I-118</subfield></datafield><datafield tag="060" ind1=" " ind2="4"><subfield code="a">QZ 200</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">003040</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">009000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">029000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">048000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">TEC</subfield><subfield code="x">059000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">610.28</subfield><subfield code="2">23</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Nanotechnology and Oncology :</subfield><subfield code="b">Workshop Summary /</subfield><subfield code="c">Margie Patlak and Christine Micheel, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Washington, D.C. :</subfield><subfield code="b">National Academies Press,</subfield><subfield code="c">©2011.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (xii, 106 pages :)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references (pages 69-71).</subfield></datafield><datafield tag="505" ind1="0" ind2="0"><subfield code="t">Introduction --</subfield><subfield code="t">Uses of Nanotechnology in Oncology and Cancer Research --</subfield><subfield code="t">Research and Development of New Cancer Nanomedicines -- Challenges and Solutions --</subfield><subfield code="t">Risks Associated with Nanotechnology --</subfield><subfield code="t">Standards and Regulation --</subfield><subfield code="t">Nanotechnology and the Public --</subfield><subfield code="t">Additional Challenges --</subfield><subfield code="t">Concluding Remarks.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">"One way scientists are working to overcome challenges in cancer treatment and improve cancer care is through nanotechnology. Nanotechnology, engineered materials that make use of the unique physical properties, presents a new array of medical prospects that will revolutionize cancer prevention, diagnosis, and treatment practices. Giving new hope to patients, practitioners, and researchers alike, nanotechnology has the potential to translate recent discoveries in cancer biology into clinical advances in oncology. While public investments in nanotechnology for cancer continue to increase, medical products based on nanotechnology are already on the market. The National Cancer Policy forum held a workshop July 12-13, 2010, to explore challenges in the use of nanotechnology in oncology. Nanotechnology and Oncology evaluates the ongoing discussion on the role of nanotechnology in cancer as it relates to risk management, treatment, and regulatory policy. Assessments on nanomedicine and the physical properties of nanomaterials were presented during the workshop, along with an appraisal of the current status of research and development efforts."--Publisher's Website</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Print version record.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Nanomedicine</subfield><subfield code="v">Congresses.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Oncology</subfield><subfield code="x">Research</subfield><subfield code="z">United States</subfield><subfield code="v">Congresses.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Nanotechnology</subfield><subfield code="v">Congresses.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Cancer</subfield><subfield code="x">Treatment</subfield><subfield code="v">Congresses.</subfield></datafield><datafield tag="650" ind1="1" ind2="2"><subfield code="a">Neoplasms</subfield><subfield code="x">therapy</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D009369Q000628</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Cancérologie</subfield><subfield code="x">Recherche</subfield><subfield code="z">États-Unis</subfield><subfield code="v">Congrès.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Cancer</subfield><subfield code="x">Traitement</subfield><subfield code="v">Congrès.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Nanomédecine</subfield><subfield code="v">Congrès.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Nanotechnologie</subfield><subfield code="v">Congrès.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Allied Health Services</subfield><subfield code="x">Medical Technology.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Biotechnology.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Family & General Practice.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Lasers in Medicine.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">TECHNOLOGY & ENGINEERING</subfield><subfield code="x">Biomedical.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cancer</subfield><subfield code="x">Treatment</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Nanomedicine</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Nanotechnology</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Oncology</subfield><subfield code="x">Research</subfield><subfield code="2">fast</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">United States</subfield><subfield code="2">fast</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq</subfield></datafield><datafield tag="655" ind1=" " ind2="2"><subfield code="a">Congress</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D016423</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">proceedings (reports)</subfield><subfield code="2">aat</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">Conference papers and proceedings</subfield><subfield code="2">fast</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">Conference papers and proceedings.</subfield><subfield code="2">lcgft</subfield><subfield code="0">http://id.loc.gov/authorities/genreForms/gf2014026068</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">Actes de congrès.</subfield><subfield code="2">rvmgf</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Patlak, Margie.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Micheel, Christine.</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.).</subfield><subfield code="b">Planning Committee on Policy Issues in Nanotechnology and Oncology.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n2011183420</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">National Cancer Policy Forum (U.S.)</subfield><subfield code="0">http://id.loc.gov/authorities/names/n2006183479</subfield></datafield><datafield tag="758" ind1=" " ind2=" "><subfield code="i">has work:</subfield><subfield code="a">Nanotechnology and Oncology (Text)</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCFwhKGhgMmbYmD6tPTHcT3</subfield><subfield code="4">https://id.oclc.org/worldcat/ontology/hasWork</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="t">Nanotechnology and oncology.</subfield><subfield code="d">Washington, D.C. : National Academies Press, ©2011</subfield><subfield code="z">0309163218</subfield><subfield code="w">(OCoLC)705518868</subfield></datafield><datafield tag="856" ind1="1" ind2=" "><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=375279</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="1" ind2=" "><subfield code="l">CBO01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=375279</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Askews and Holts Library Services</subfield><subfield code="b">ASKH</subfield><subfield code="n">AH36617945</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Askews and Holts Library Services</subfield><subfield code="b">ASKH</subfield><subfield code="n">AH36559524</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Coutts Information Services</subfield><subfield code="b">COUT</subfield><subfield code="n">18113815</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest Ebook Central</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL3378852</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ebrary</subfield><subfield code="b">EBRY</subfield><subfield code="n">ebr10495452</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">375279</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest MyiLibrary Digital eBook Collection</subfield><subfield code="b">IDEB</subfield><subfield code="n">315173</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">7082324</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Internet Archive</subfield><subfield code="b">INAR</subfield><subfield code="n">nanotechnologyon0000unse</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield></record></collection> |
| genre | Congress https://id.nlm.nih.gov/mesh/D016423 proceedings (reports) aat Conference papers and proceedings fast Conference papers and proceedings. lcgft http://id.loc.gov/authorities/genreForms/gf2014026068 Actes de congrès. rvmgf |
| genre_facet | Congress proceedings (reports) Conference papers and proceedings Conference papers and proceedings. Actes de congrès. |
| geographic | United States fast https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq |
| geographic_facet | United States |
| id | ZDB-4-EBA-ocn746945424 |
| illustrated | Illustrated |
| indexdate | 2024-10-25T16:18:14Z |
| institution | BVB |
| institution_GND | http://id.loc.gov/authorities/names/n2011183420 http://id.loc.gov/authorities/names/n2006183479 |
| isbn | 9780309163224 0309163226 1283151731 9781283151733 9786613151735 6613151734 0309305594 9780309305594 |
| language | English |
| lccn | 2012472834 |
| oclc_num | 746945424 |
| open_access_boolean | |
| owner | MAIN |
| owner_facet | MAIN |
| physical | 1 online resource (xii, 106 pages :) |
| psigel | ZDB-4-EBA |
| publishDate | 2011 |
| publishDateSearch | 2011 |
| publishDateSort | 2011 |
| publisher | National Academies Press, |
| record_format | marc |
| spelling | Nanotechnology and Oncology : Workshop Summary / Margie Patlak and Christine Micheel, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies. Washington, D.C. : National Academies Press, ©2011. 1 online resource (xii, 106 pages :) text txt rdacontent computer c rdamedia online resource cr rdacarrier Includes bibliographical references (pages 69-71). Introduction -- Uses of Nanotechnology in Oncology and Cancer Research -- Research and Development of New Cancer Nanomedicines -- Challenges and Solutions -- Risks Associated with Nanotechnology -- Standards and Regulation -- Nanotechnology and the Public -- Additional Challenges -- Concluding Remarks. "One way scientists are working to overcome challenges in cancer treatment and improve cancer care is through nanotechnology. Nanotechnology, engineered materials that make use of the unique physical properties, presents a new array of medical prospects that will revolutionize cancer prevention, diagnosis, and treatment practices. Giving new hope to patients, practitioners, and researchers alike, nanotechnology has the potential to translate recent discoveries in cancer biology into clinical advances in oncology. While public investments in nanotechnology for cancer continue to increase, medical products based on nanotechnology are already on the market. The National Cancer Policy forum held a workshop July 12-13, 2010, to explore challenges in the use of nanotechnology in oncology. Nanotechnology and Oncology evaluates the ongoing discussion on the role of nanotechnology in cancer as it relates to risk management, treatment, and regulatory policy. Assessments on nanomedicine and the physical properties of nanomaterials were presented during the workshop, along with an appraisal of the current status of research and development efforts."--Publisher's Website Print version record. English. Nanomedicine Congresses. Oncology Research United States Congresses. Nanotechnology Congresses. Cancer Treatment Congresses. Neoplasms therapy https://id.nlm.nih.gov/mesh/D009369Q000628 Cancérologie Recherche États-Unis Congrès. Cancer Traitement Congrès. Nanomédecine Congrès. Nanotechnologie Congrès. MEDICAL Allied Health Services Medical Technology. bisacsh MEDICAL Biotechnology. bisacsh MEDICAL Family & General Practice. bisacsh MEDICAL Lasers in Medicine. bisacsh TECHNOLOGY & ENGINEERING Biomedical. bisacsh Cancer Treatment fast Nanomedicine fast Nanotechnology fast Oncology Research fast United States fast https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq Congress https://id.nlm.nih.gov/mesh/D016423 proceedings (reports) aat Conference papers and proceedings fast Conference papers and proceedings. lcgft http://id.loc.gov/authorities/genreForms/gf2014026068 Actes de congrès. rvmgf Patlak, Margie. Micheel, Christine. Institute of Medicine (U.S.). Planning Committee on Policy Issues in Nanotechnology and Oncology. http://id.loc.gov/authorities/names/n2011183420 National Cancer Policy Forum (U.S.) http://id.loc.gov/authorities/names/n2006183479 has work: Nanotechnology and Oncology (Text) https://id.oclc.org/worldcat/entity/E39PCFwhKGhgMmbYmD6tPTHcT3 https://id.oclc.org/worldcat/ontology/hasWork Print version: Nanotechnology and oncology. Washington, D.C. : National Academies Press, ©2011 0309163218 (OCoLC)705518868 FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=375279 Volltext CBO01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=375279 Volltext |
| spellingShingle | Nanotechnology and Oncology : Workshop Summary / Introduction -- Uses of Nanotechnology in Oncology and Cancer Research -- Research and Development of New Cancer Nanomedicines -- Challenges and Solutions -- Risks Associated with Nanotechnology -- Standards and Regulation -- Nanotechnology and the Public -- Additional Challenges -- Concluding Remarks. Nanomedicine Congresses. Oncology Research United States Congresses. Nanotechnology Congresses. Cancer Treatment Congresses. Neoplasms therapy https://id.nlm.nih.gov/mesh/D009369Q000628 Cancérologie Recherche États-Unis Congrès. Cancer Traitement Congrès. Nanomédecine Congrès. Nanotechnologie Congrès. MEDICAL Allied Health Services Medical Technology. bisacsh MEDICAL Biotechnology. bisacsh MEDICAL Family & General Practice. bisacsh MEDICAL Lasers in Medicine. bisacsh TECHNOLOGY & ENGINEERING Biomedical. bisacsh Cancer Treatment fast Nanomedicine fast Nanotechnology fast Oncology Research fast |
| subject_GND | https://id.nlm.nih.gov/mesh/D009369Q000628 https://id.nlm.nih.gov/mesh/D016423 http://id.loc.gov/authorities/genreForms/gf2014026068 |
| title | Nanotechnology and Oncology : Workshop Summary / |
| title_alt | Introduction -- Uses of Nanotechnology in Oncology and Cancer Research -- Research and Development of New Cancer Nanomedicines -- Challenges and Solutions -- Risks Associated with Nanotechnology -- Standards and Regulation -- Nanotechnology and the Public -- Additional Challenges -- Concluding Remarks. |
| title_auth | Nanotechnology and Oncology : Workshop Summary / |
| title_exact_search | Nanotechnology and Oncology : Workshop Summary / |
| title_full | Nanotechnology and Oncology : Workshop Summary / Margie Patlak and Christine Micheel, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies. |
| title_fullStr | Nanotechnology and Oncology : Workshop Summary / Margie Patlak and Christine Micheel, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies. |
| title_full_unstemmed | Nanotechnology and Oncology : Workshop Summary / Margie Patlak and Christine Micheel, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies. |
| title_short | Nanotechnology and Oncology : |
| title_sort | nanotechnology and oncology workshop summary |
| title_sub | Workshop Summary / |
| topic | Nanomedicine Congresses. Oncology Research United States Congresses. Nanotechnology Congresses. Cancer Treatment Congresses. Neoplasms therapy https://id.nlm.nih.gov/mesh/D009369Q000628 Cancérologie Recherche États-Unis Congrès. Cancer Traitement Congrès. Nanomédecine Congrès. Nanotechnologie Congrès. MEDICAL Allied Health Services Medical Technology. bisacsh MEDICAL Biotechnology. bisacsh MEDICAL Family & General Practice. bisacsh MEDICAL Lasers in Medicine. bisacsh TECHNOLOGY & ENGINEERING Biomedical. bisacsh Cancer Treatment fast Nanomedicine fast Nanotechnology fast Oncology Research fast |
| topic_facet | Nanomedicine Congresses. Oncology Research United States Congresses. Nanotechnology Congresses. Cancer Treatment Congresses. Neoplasms therapy Cancérologie Recherche États-Unis Congrès. Cancer Traitement Congrès. Nanomédecine Congrès. Nanotechnologie Congrès. MEDICAL Allied Health Services Medical Technology. MEDICAL Biotechnology. MEDICAL Family & General Practice. MEDICAL Lasers in Medicine. TECHNOLOGY & ENGINEERING Biomedical. Cancer Treatment Nanomedicine Nanotechnology Oncology Research United States Congress proceedings (reports) Conference papers and proceedings Conference papers and proceedings. Actes de congrès. |
| url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=375279 |
| work_keys_str_mv | AT patlakmargie nanotechnologyandoncologyworkshopsummary AT micheelchristine nanotechnologyandoncologyworkshopsummary AT instituteofmedicineusplanningcommitteeonpolicyissuesinnanotechnologyandoncology nanotechnologyandoncologyworkshopsummary AT nationalcancerpolicyforumus nanotechnologyandoncologyworkshopsummary |